CN100434080C - A medicine for treating dermatosis - Google Patents
A medicine for treating dermatosis Download PDFInfo
- Publication number
- CN100434080C CN100434080C CNB200610083328XA CN200610083328A CN100434080C CN 100434080 C CN100434080 C CN 100434080C CN B200610083328X A CNB200610083328X A CN B200610083328XA CN 200610083328 A CN200610083328 A CN 200610083328A CN 100434080 C CN100434080 C CN 100434080C
- Authority
- CN
- China
- Prior art keywords
- present
- medicine
- weight
- tinea
- parts
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Abstract
The present invention relates to a medicine, particularly to a medicine for treating skin diseases. The present invention provides a medicine for treating skin diseases, which is prepared from the following raw material medicines: 0.2 to 1.6 parts by weight of halcinonide, 2 to 10 parts by weight of prednisone acetate, 0.1 to 0.6 part by weight of diphenhydramine hydrochloride, 80 to 160 parts by weight of chloramphenicol, 30 to 120 parts by weight of griseofulvin, 100 to 260 parts by weight of sulfur and 0.5 to 1.0 part by weight of dexamethasone. The present invention also provides a method for preparing the medicine for treating skin diseases. The product of the present invention is suitable for various skin diseases caused by mycotic infection, can promote the protein synthesis of skin cells and prompt healing. The observation data of clinical application indicates that the cure rate of the product of the present invention reaches 95%, and the effective rate reaches 100%.
Description
Technical field
The present invention relates to a kind of medicine, particularly relate to the dermopathic medicine of a kind of treatment.
Background technology
Be referred to as " mycosis " by fungus-caused disease, wherein the sickness rate with tinea is the highest, can occur in parts of body, locates as perineum, hands, foot etc.Fungus happiness warm moist, the optimum temperature of superficial mycosis is 22 ℃～28 ℃:, too drying also is unfavorable for fungi growth.Therefore summer the sickness rate height, especially China's southern area is higher.In addition, the local skin situation also is the key factor that determines whether to take place tinea.For example often wear the people of rubber overshoes or leather shoes, because breathability is poor, the humidity of foot and increase in temperature, fungus very easily grows and tinea takes place in this case.
But up to the present, the dermopathic curative effect of medication that various treatments cause because of fungal infection is not very definite.Though the medicine determined curative effect that has, toxic side effect stimulates human body skin.
Summary of the invention
The objective of the invention is to overcome uncertain therapeutic efficacy that prior art exists and cut and have defective such as toxic and side effects, a kind of determined curative effect, the dermopathic medicine of treatment cheap, that have no side effect are provided.
Technical scheme of the present invention is as follows:
The invention provides the dermopathic medicine of a kind of treatment, its active ingredient is made up of the crude drug of following parts by weight:
Halcinonide 0.2-1.6;
Prednisoni acetas 2-10;
Diphhydramine hydrochloride 0.1-0.6;
Chloromycetin 80-160;
Griseofulvin 30-120;
Sulfur 100-260;
Dexamethasone 0.5-1.0.
As prioritization scheme, the dermopathic medicine of treatment provided by the present invention also includes an amount of Herba Menthae powder and camphor powder.
As prioritization scheme, the dermopathic medicine of treatment provided by the present invention also includes sodium benzoate 0.01-10 part, as antiseptic.
The present invention also provides the preparation method of the dermopathic medicine of described treatment as follows:
After the crude drug pulverizing with described amount, adding pharmaceutically after the mixing, the acceptable solvent is modulated into paste.
Described solvent is water or ethanol.
Usage and consumption: clean the part with light salt brine or light vinegar water earlier, dry the back and smear the affected part, 2-3 time on the one, smear once before sleeping evening with medicine provided by the present invention.Continue behind the transference cure to use a week to consolidate curative effect.
Product of the present invention is a broad spectrum antibiotic, and its pharmacological action is suppress cell membrane synthetic, particularly tinea fungus, candidiasis, mycete, anaerobe etc. is had killing action.The dermatosis that product adaptation of the present invention causes in various fungal infection as psoriasis, tinea pedis, tinea corporis, tinea cruris, the tinea manuum, tinea versicolor and various dermatitis etc., can promote skin cell protein synthetic, impels healing.The observation on Clinical Application data show that product treatment rate of the present invention reaches 95%, and effective percentage 100% finds no toxic and side effects, and determined curative effect, and onset is quick, and is cheap, easy to use, is worth of widely use.
The specific embodiment
Below by specific embodiment the present invention is described.
Embodiment 1
The prescription that present embodiment adopted is as follows:
Halcinonide 1;
Prednisoni acetas 6;
Diphhydramine hydrochloride 0.3;
Chloromycetin 200;
Griseofulvin 80;
Sulfur 200;
Dexamethasone 0.75.
Processing technology: the crude drug of described amount is pulverized, added water after the mixing, be modulated into paste.
Usage and consumption: clean the part with light salt brine or light vinegar water earlier, dry the back and smear the affected part, 2-3 time on the one, smear once before sleeping evening with medicine provided by the present invention.Continue behind the transference cure to use a week to consolidate curative effect.
The applicable cases explanation:
Use Drug therapy dermatosis patient 60 people provided by the present invention, wherein, psoriasis 20 people, lamellar eczema 15 people, tinea corporis 21 people, other 4 people.Use medicine provided by the present invention by above-mentioned usage and dosage, all recoveries from illness, and do not see recurrence.
Product of the present invention is a broad spectrum antibiotic, and its pharmacological action is suppress cell membrane synthetic, particularly tinea fungus, candidiasis, mycete, anaerobe etc. is had killing action.The dermatosis that product adaptation of the present invention causes in various fungal infection as psoriasis, tinea pedis, tinea corporis, tinea cruris, the tinea manuum, tinea versicolor and various dermatitis etc., can promote skin cell protein synthetic, impels healing.The observation on Clinical Application data show that product treatment rate of the present invention reaches 95%, and effective percentage 100% finds no toxic and side effects, and determined curative effect, and onset is quick, and is cheap, easy to use, is worth of widely use.
Embodiment 2
The prescription that present embodiment adopted is as follows:
Halcinonide 0.2;
Prednisoni acetas 10;
Diphhydramine hydrochloride 0.1;
Chloromycetin 160;
Griseofulvin 30;
Sulfur 260;
Dexamethasone 0.5.
Processing technology: the crude drug of described amount is pulverized, added water after the mixing, be modulated into paste.
Usage and consumption: clean the part with light salt brine or light vinegar water earlier, dry the back and smear the affected part, 2-3 time on the one, smear once before sleeping evening with medicine provided by the present invention.Continue behind the transference cure to use a week to consolidate curative effect.
The applicable cases explanation:
Use Drug therapy dermatosis patient 62 people provided by the present invention, wherein, psoriasis 20 people, lamellar eczema 15 people, tinea corporis 22 people, other 5 people.Use medicine provided by the present invention by above-mentioned usage and dosage, all recoveries from illness, and do not see recurrence.
Product of the present invention is a broad spectrum antibiotic, and its pharmacological action is suppress cell membrane synthetic, particularly tinea fungus, candidiasis, mycete, anaerobe etc. is had killing action.The dermatosis that product adaptation of the present invention causes in various fungal infection as psoriasis, tinea pedis, tinea corporis, tinea cruris, the tinea manuum, tinea versicolor and various dermatitis etc., can promote skin cell protein synthetic, impels healing.The observation on Clinical Application data show that product treatment rate of the present invention reaches 95%, and effective percentage 100% finds no toxic and side effects, and determined curative effect, and onset is quick, and is cheap, easy to use, is worth of widely use.
Embodiment 3
The prescription that present embodiment adopted is as follows:
Halcinonide 1.6;
Prednisoni acetas 2;
Diphhydramine hydrochloride 0.6;
Chloromycetin 80;
Griseofulvin 120;
Sulfur 100;
Dexamethasone 1.0.
Processing technology: the crude drug of described amount is pulverized, added ethanol after the mixing, be modulated into paste, add 10 parts of sodium benzoate
Usage and consumption: clean the part with light salt brine or light vinegar water earlier, dry the back and smear the affected part, 2-3 time on the one, smear once before sleeping evening with medicine provided by the present invention.Continue behind the transference cure to use a week to consolidate curative effect.
The applicable cases explanation:
Use Drug therapy dermatosis patient 61 people provided by the present invention, wherein, psoriasis 20 people, lamellar eczema 15 people, tinea corporis 22 people, other 4 people.Use medicine provided by the present invention by above-mentioned usage and dosage, all recoveries from illness, and do not see recurrence.
Product of the present invention is a broad spectrum antibiotic, and its pharmacological action is suppress cell membrane synthetic, particularly tinea fungus, candidiasis, mycete, anaerobe etc. is had killing action.The dermatosis that product adaptation of the present invention causes in various fungal infection as psoriasis, tinea pedis, tinea corporis, tinea cruris, the tinea manuum, tinea versicolor and various dermatitis etc., can promote skin cell protein synthetic, impels healing.The observation on Clinical Application data show that product treatment rate of the present invention reaches 95%, and effective percentage 100% finds no toxic and side effects, and determined curative effect, and onset is quick, and is cheap, easy to use, is worth of widely use.
Embodiment 4
The prescription that present embodiment adopted is as follows:
Halcinonide 0.2;
Prednisoni acetas 2;
Diphhydramine hydrochloride 0.6;
Chloromycetin 160;
Griseofulvin 30;
Sulfur 100;
Dexamethasone 1.0.
Processing technology: the crude drug of described amount is pulverized, added water after the mixing, be modulated into paste.
Usage and consumption: clean the part with light salt brine or light vinegar water earlier, dry the back and smear the affected part, 2-3 time on the one, smear once before sleeping evening with medicine provided by the present invention.Continue behind the transference cure to use a week to consolidate curative effect.
The applicable cases explanation:
Use Drug therapy dermatosis patient 60 people provided by the present invention, wherein, psoriasis 20 people, lamellar eczema 15 people, tinea corporis 20 people, other 5 people.Use medicine provided by the present invention by above-mentioned usage and dosage, all recoveries from illness, and do not see recurrence.
Product of the present invention is a broad spectrum antibiotic, and its pharmacological action is suppress cell membrane synthetic, particularly tinea fungus, candidiasis, mycete, anaerobe etc. is had killing action.The dermatosis that product adaptation of the present invention causes in various fungal infection as psoriasis, tinea pedis, tinea corporis, tinea cruris, the tinea manuum, tinea versicolor and various dermatitis etc., can promote skin cell protein synthetic, impels healing.The observation on Clinical Application data show that product treatment rate of the present invention reaches 95%, and effective percentage 100% finds no toxic and side effects, and determined curative effect, and onset is quick, and is cheap, easy to use, is worth of widely use.
Embodiment 5
The prescription that present embodiment adopted is as follows:
Halcinonide solution 5ml (Tangshan Wanqingren Pharmaceutical Co., Ltd. produces, and every ml contains halcinonide 0.125g); 6 of prednisoni acetass (Kaifeng pharmacy Group Co.,Ltd produces every 5mg); 6 of diphhydramine hydrochlorides (Kaifeng pharmacy Group Co.,Ltd produces every 0.25mg); 4 in chloromycetin (Kaifeng pharmacy Group Co.,Ltd produces every 0.25g); 4 of griseofulvin (the sharp monarch in Xi'an pharmaceutical Co. Ltd produces every 0.1g); Compound sulfur emulsifiable paste 1g (Kaifeng Dragon Pavilion pharmaceutcal corporation, Ltd); Compound recipe dexamethasone ointment 5g (White Cloud Mountain, Guangzhou pharmaceutical Co. Ltd produces, and every gram contains dexamethasone 0.75mg).
Processing technology:
With described content of starting materials mixing, the furnishing pasty state adds 0.01 part of an amount of Herba Menthae powder and camphor powder and sodium benzoate then.
Usage and consumption: clean the part with light salt brine or light vinegar water earlier, dry the back and smear the affected part, 2-3 time on the one, smear once before sleeping evening with medicine provided by the present invention.Continue behind the transference cure to use a week to consolidate curative effect.
The applicable cases explanation:
Use Drug therapy dermatosis patient 59 people provided by the present invention, wherein, psoriasis 20 people, lamellar eczema 15 people, tinea corporis 20 people, other 4 people.Use medicine provided by the present invention by above-mentioned usage and dosage, all recoveries from illness, and do not see recurrence.
Product of the present invention is a broad spectrum antibiotic, and its pharmacological action is suppress cell membrane synthetic, particularly tinea fungus, candidiasis, mycete, anaerobe etc. is had killing action.The dermatosis that product adaptation of the present invention causes in various fungal infection as psoriasis, tinea pedis, tinea corporis, tinea cruris, the tinea manuum, tinea versicolor and various dermatitis etc., can promote skin cell protein synthetic, impels healing.The observation on Clinical Application data show that product treatment rate of the present invention reaches 95%, and effective percentage 100% finds no toxic and side effects, and determined curative effect, and onset is quick, and is cheap, easy to use, is worth of widely use.
Model case is given an example:
Case 1: Guo, man, 30 years old, Han nationality.Private prosecution is head portion large tracts of land white snow skin, Pruritus over 6 years, the time heavy when light.Used multiple Drug therapy, but poor effect.Have a medical check-up during prescription on individual diagnosis, the part exceeds skin, and punctation etc. is arranged, and tentative diagnosis is a psoriasis.Take a turn for the better recovery from illness end recurrence so far after ten days after seven days with medicine of the present invention.
Case 2: Wang, woman, 18 years old, Han nationality.Before the lower limb of the private prosecution left and right sides partially in red, itch, flow yellow fluid.Be diagnosed as lamellar eczema through the county hospital department of dermatologry, but fail to respond to any medical treatment.Smear the medicine of the present invention wood recurrence of fully recovering after ten days so far.
Case 3: male patient 21 years old, there is the round tinea corporis of the 15 * 17cm of three places at private prosecution shoulder, back, itch.Be diagnosed as tinea circinata after the prescription on individual diagnosis, smear medicine of the present invention and fully recover after eight days, do not recur half a year.
Case 4: certain man, 41 years old, coal miner, after shouldering wooden 12 hours before private prosecution was gone to a doctor two days, red, the speckle of itching appears in two forearms, exceeds skin, blister appears after one day, in the form of sheets, smear medicine of the present invention after salt, vinegar washing, blister disappears two days later, symptom takes a turn for the better after three days, not recurrence of recovery from illness after seven days.
Claims (3)
1. treat dermopathic medicine for one kind, it is characterized in that its active ingredient is made up of the crude drug of following parts by weight:
Halcinonide 0.2-1.6;
Prednisoni acetas 2-10;
Diphhydramine hydrochloride 0.1-0.6;
Chloromycetin 80-160;
Griseofulvin 30-120;
Sulfur 100-260;
Dexamethasone 0.5-1.0.
2. the dermopathic medicine of treatment according to claim 1 is characterized in that described medicine also includes sodium benzoate 0.01-10 part.
3. the preparation method of the dermopathic medicine of the described treatment of claim 1 is as follows:
After the crude drug pulverizing with described amount, adding pharmaceutically after the mixing, the acceptable solvent is modulated into paste.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB200610083328XA CN100434080C (en) | 2006-06-02 | 2006-06-02 | A medicine for treating dermatosis |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB200610083328XA CN100434080C (en) | 2006-06-02 | 2006-06-02 | A medicine for treating dermatosis |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1883550A CN1883550A (en) | 2006-12-27 |
| CN100434080C true CN100434080C (en) | 2008-11-19 |
Family
ID=37581932
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNB200610083328XA Expired - Fee Related CN100434080C (en) | 2006-06-02 | 2006-06-02 | A medicine for treating dermatosis |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN100434080C (en) |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1615889A (en) * | 2003-11-14 | 2005-05-18 | 李中变 | Medicine for treating skin disease |
-
2006
- 2006-06-02 CN CNB200610083328XA patent/CN100434080C/en not_active Expired - Fee Related
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1615889A (en) * | 2003-11-14 | 2005-05-18 | 李中变 | Medicine for treating skin disease |
Non-Patent Citations (1)
| Title |
|---|
| 1992年皮肤病的治疗. 中国医学科学院，中国协和医科大学皮肤病研究所.国外医学皮肤性病学分册，第20卷第6期. 1994 * |
Also Published As
| Publication number | Publication date |
|---|---|
| CN1883550A (en) | 2006-12-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Yu et al. | Inhibitory effects of the Gentiana macrophylla (Gentianaceae) extract on rheumatoid arthritis of rats | |
| Balamurugan et al. | Anti-inflammatory and anti-pyretic activities of earthworm extract—Lampito mauritii (Kinberg) | |
| CN101417060B (en) | Plaster capable of treating trauma, traumatic injury, alopecia areata and burn and scald | |
| CN101785836A (en) | Traditional Chinese medicine ointment, preparation method and application thereof for skin disease treatment | |
| CN105285986A (en) | Health food or pharmaceutical composition comprising chestnut shell extract | |
| CN101708241B (en) | Medicinal composition for eliminating dampness and relieving itching | |
| CN101129409B (en) | Antimycotic externally used drug | |
| CN1615889A (en) | Medicine for treating skin disease | |
| CN101259149A (en) | Tinctura for treating beriberi | |
| CN100434080C (en) | A medicine for treating dermatosis | |
| CN104161763B (en) | A kind of pharmaceutical composition is as preparing the application treated in dermatitis and eczema | |
| CN106902133A (en) | One kind treats dermopathic medicine | |
| CN101628067B (en) | Medicament for treating diskal hernia and arthralgia | |
| CN109381483A (en) | It is a kind of to treat dermopathic drug | |
| CN102671076B (en) | Medicament for treating gout | |
| CN102727834B (en) | Traditional Chinese medicine composition for treating migraine, and preparation method and application thereof | |
| CN101607009B (en) | Pharmaceutical composition for treating cold | |
| CN105250330A (en) | Compound salicylic acid beriberi powder for treating beriberi and preparation method thereof | |
| WO2017088177A1 (en) | Mussel adhesive protein product, and use thereof in preventing and suppressing neuronal inflammation | |
| CN102283982B (en) | Medicinal composition for treating skin diseases | |
| CN105902722B (en) | Traditional Chinese medicine composition for treating leucoderma as well as preparation method and application thereof | |
| CN109223815A (en) | A kind of purposes of pharmaceutical composition in preparation treatment acetyl cholinergic urticaria drug | |
| CN104997726A (en) | External use emulsifiable paste for preventing and treating skin tinea | |
| EP3013330B1 (en) | Anti-viral compound and composition | |
| Zou et al. | Regeneration and Repair of an Acute Thumb Trauma using the Natural Plant Antimicrobial Solution |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C17 | Cessation of patent right | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20081119 Termination date: 20110602 |